Report Categories
View AllRecent Articles
View All
VNCE Vince Holding posts 782 percent Q1 2026 EPS surprise far exceeding analyst consensus projections
SGP SpyGlass Pharma reports solid latestage trial progress lays out aggressive commercial expansion plans for 2025
The key driver behind CreditAccept CACC revenue growth Q1 2026 Profit Disappoints
What Celestica CLS is doing to stay ahead Flirts with Support 20260506